Neural Therapeutics Inc.
Neural Therapeutics Inc.
Indice CSE:
Devise:
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company’s innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Neural Therapeutics Inc. (NURL)
Information d'entreprise
Addresse
3002-130 Adelaide St. W.
Toronto, ON M5H 3P5
CanadaTéléphone
647-697-6875Courriel
info@neuraltherapeutics.comURL
http://www.neuraltherapeutics.caDate d’inscription à la cote
Lundi, mars 17, 2025
Agent de transfert
Odyssey Trust CompanySEDAR Information
Information d'entreprise
Addresse
3002-130 Adelaide St. W.
Toronto, ON M5H 3P5
CanadaTéléphone
647-697-6875Courriel
info@neuraltherapeutics.comURL
http://www.neuraltherapeutics.caDate d’inscription à la cote
Lundi, mars 17, 2025
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
88700524Réservé à l'émission:
31203436Company Officers
Ian Campbell, Chief Executive Officer
Omar Gonzalez, Chief Financial Officer